These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 8688890)
1. The influence of new 9-(omega-[4-(2-pyrimidinyl)-1-piperazinyl]alkyl) pyrimidino[2,1-f]purines on the central nervous system. Malec D; Modzelewski J; Drabczyńska A; Pawłowski M; Gorczyca M Pol J Pharmacol; 1995; 47(2):169-73. PubMed ID: 8688890 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and preliminary pharmacological assessment of novel 9-alkylamino substituted pyrimidino-[2,1-f]-purines. Drabczyńska A; Pawłowski M; Gorczyca M; Malec D; Modzelewski J Pol J Pharmacol Pharm; 1992; 44(5):487-503. PubMed ID: 1297113 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and preliminary pharmacological assessment of novel 9-substituted pyrimidino-[2,1-f]-purines. Pawłowski M; Drabczyńska A; Gorczyca M; Malec D; Modzelewski J Pol J Pharmacol Pharm; 1991; 43(1):61-70. PubMed ID: 1771164 [TBL] [Abstract][Full Text] [Related]
4. Chemical and pharmacological properties of new tetrahydropyrimido-[2,1-f]-purines. Pawłowski M; Drabczyńska A; Gorczyca M; Malec D; Modzelewski J Pharmazie; 1995 Jul; 50(7):453-5. PubMed ID: 7675886 [TBL] [Abstract][Full Text] [Related]
5. Investigations on the synthesis and properties of some N-[4-phenyl(2-pyrimidinyl)-1-piperazinyl]alkyl (hydroxyalkyl)-3,4-pyridinedicarboximides. Sladowska H; Potoczek J; Rajtar G; Sieklucka-Dziuba M; Zółkowska D; Kleinrok Z Acta Pol Pharm; 1996; 53(6):417-24. PubMed ID: 9415216 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological screening of novel 10-substituted diazepino-[2,1-f]-purines. Pawłowski M; Drabczyńska A; Gorczyca M; Malec D; Modzelewski J Acta Pol Pharm; 1994; 51(4-5):385-91. PubMed ID: 7701952 [TBL] [Abstract][Full Text] [Related]
7. Phenylethyl-substituted pyrimido[2,1-f]purinediones and related compounds: structure-activity relationships as adenosine A(1) and A(2A) receptor ligands. Drabczyńska A; Müller CE; Schiedel A; Schumacher B; Karolak-Wojciechowska J; Fruziński A; Zobnina W; Yuzlenko O; Kieć-Kononowicz K Bioorg Med Chem; 2007 Nov; 15(22):6956-74. PubMed ID: 17827019 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of derivatives of N-[4-substituted-1-piperazinylalkyl]-1-(butyl,aryl)-2,5- dimethylpyrrole-3,4-dicarboxymide (Part II). Malinka W; Sieklucka-Dziuba M; Robak J; Kleinrok Z Farmaco; 1994; 49(7-8):481-7. PubMed ID: 7945713 [TBL] [Abstract][Full Text] [Related]
9. [The synthesis of new pyrrolidone derivatives with psychotropic action]. Stefănescu E; Petrovanu M; Ciocoiu I; Caproşu M; Bîcu E Rev Med Chir Soc Med Nat Iasi; 1992; 96(3-4):241-2. PubMed ID: 1344862 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, 5-HT1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione. Chloń G; Pawłowski M; Duszyńska B; Szaro A; Tatarczńska E; Kłodzińska AL; Chojnacka-Wójcik E Pol J Pharmacol; 2001; 53(4):359-68. PubMed ID: 11990082 [TBL] [Abstract][Full Text] [Related]
11. Diazepinoquinazolines. Part II. Synthesis and pharmacological activity of some derivatives of 1,4-diazepino[2,1-b]quinazoline. Guryn R; Szadowska A; Pakulska W Acta Pol Pharm; 1994; 51(6):483-7. PubMed ID: 7762399 [TBL] [Abstract][Full Text] [Related]
12. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation. Jurczyk S; Kołaczkowski M; Maryniak E; Zajdel P; Pawłowski M; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E; Bojarski AJ; Charakchieva-Minol S; Duszyńska B; Nowak G; Maciag D J Med Chem; 2004 May; 47(10):2659-66. PubMed ID: 15115407 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacological activity of the optical isomers of sydnocarb]. Al'tshuler RA; Mashkovskiĭ MD Farmakol Toksikol; 1980; 43(4):345-9. PubMed ID: 7439363 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological evaluation of N-aryl(pyrimidinyl) piperazinylalkyl (hydroxyalkyl) derivatives of 1,2,3,4-tetra- and 1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazines. Sladowska H; Potoczek J; Rajtar G; Sieklucka-Dziuba M; Młynarczyk M; Kleinrok Z Farmaco; 1996 Jun; 51(6):431-6. PubMed ID: 8766227 [TBL] [Abstract][Full Text] [Related]
15. [Effect of a membrane modulator from the 3-hydroxypyridine class on the pharmacological activity of a number of psychotropic preparations]. Smirnov LD; Voronina TA; Diumaev KM Biull Eksp Biol Med; 1985 May; 99(5):519-22. PubMed ID: 4005401 [TBL] [Abstract][Full Text] [Related]
16. Neuropharmacological activity of newly-synthesized derivatives of 3,3-diethyl-2,4-pyridinedione. V. Relation between chemical structure and pharmacological activity. Belcheva I; Stoytchev T Acta Physiol Pharmacol Bulg; 1983; 9(4):37-47. PubMed ID: 6677062 [TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of N-benzylpiperidine-purine derivatives as new dual inhibitors of acetyl- and butyrylcholinesterase. Rodríguez-Franco MI; Fernández-Bachiller MI; Pérez C; Castro A; Martínez A Bioorg Med Chem; 2005 Dec; 13(24):6795-802. PubMed ID: 16183292 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological assays and QSAR studies of N-(9-benzyl-2-phenyl-8-azapurin-6-yl)-amides as ligands for A1 adenosine receptors. Giorgi I; Leonardi M; Pietra D; Biagi G; Borghini A; Massarelli I; Ciampi O; Bianucci AM Bioorg Med Chem; 2009 Mar; 17(5):1817-30. PubMed ID: 19230680 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activity of tricyclic aryloimidazo-, pyrimido-, and diazepinopurinediones. Drabczyńska A; Müller CE; Lacher SK; Schumacher B; Karolak-Wojciechowska J; Nasal A; Kawczak P; Yuzlenko O; Pekala E; Kieć-Kononowicz K Bioorg Med Chem; 2006 Nov; 14(21):7258-81. PubMed ID: 16844379 [TBL] [Abstract][Full Text] [Related]